Cubilin and Megalin Co-localize in the Neonatal Inner Ear
Overview
Psychiatry
Authors
Affiliations
Cubilin and megalin are multifunctional endocytotic receptors expressed in many absorptive epithelia. The receptors have separate functions but may act in concert in several tissues including the small intestine, the visceral yolk sac and the renal proximal tubule to perform significant physiological functions essential to homeostasis in the extracellular fluid compartments. Because of the importance of fluid homeostasis in the inner ear, we investigated the expression of cubilin and megalin in this structure. Furthermore, we examined the binding properties of 6 different aminoglycosides (AGs) to cubilin and compared the results to data obtained for megalin, which is a well-known receptor for AGs and other polybasic substances, including several ototoxic drugs. In the cochlea, immunohistochemical labelling for cubilin showed expression corresponding to the apical surface of the strial marginal cells, to epithelial cells at the spiral prominence and to epithelial cells of Reissner's membrane facing the cochlear duct. In the vestibular apparatus, positive labelling was found in dark cells of the utricle and those flanking the crista ampullaris of the semicircular canals. Exactly the same tissue distribution was found for megalin. These findings support the prevailing view that cubilin and megalin constitute a dual-receptor complex facilitating the function of each other. The physiological role of this receptor complex in the inner ear remains unknown, although several established ligands for both cubilin and megalin are present in the inner ear fluids. Receptor-ligand interaction analysis showed that all 6 AGs bind to both receptors and with approximately the same affinity. The results demonstrate a novel role for cubilin as a drug receptor for AGs and possibly other ototoxic substances.
Ahmed M, Li J, Zhou Q Pharmaceutics. 2024; 16(3).
PMID: 38543283 PMC: 10975719. DOI: 10.3390/pharmaceutics16030389.
pharmacological study of AQP2 inhibition by steroids contextualized to Ménière's disease treatments.
Mom R, Rety S, Mocquet V, Auguin D Front Neurol. 2023; 14:1270092.
PMID: 37928160 PMC: 10620702. DOI: 10.3389/fneur.2023.1270092.
Megalin and Vitamin D Metabolism-Implications in Non-Renal Tissues and Kidney Disease.
Khan S, Petkovich M, Holden R, Adams M Nutrients. 2022; 14(18).
PMID: 36145066 PMC: 9506339. DOI: 10.3390/nu14183690.
Bioinformatic Analysis of the Perilymph Proteome to Generate a Human Protein Atlas.
van Dieken A, Staecker H, Schmitt H, Harre J, Pich A, Rossberg W Front Cell Dev Biol. 2022; 10:847157.
PMID: 35573665 PMC: 9096870. DOI: 10.3389/fcell.2022.847157.
Identifying targets to prevent aminoglycoside ototoxicity.
Kim J, Hemachandran S, Cheng A, Ricci A Mol Cell Neurosci. 2022; 120:103722.
PMID: 35341941 PMC: 9177639. DOI: 10.1016/j.mcn.2022.103722.